Opioid Use Common Among Patients With Migraine
Approximately one-third of patients with migraine reported using opioids to treat their symptoms, a practice that contrasts with current guidelines.
Headache
Galcanezumab Linked to Improved Work Productivity in Patients With Migraine
Galcanezumab was found to significantly improve work productivity and reduce interictal burden in patients with treatment-resistant migraine, according to results from the phase 3 CONQUER study.
Exploring the Link Between Pediatric Migraine & Sleep Disorders
The bidirectional relationship between migraine and sleep disorders are examined in this article.
Positive Outcomes Reported With Novel Intranasal DHE for Migraine
Positive results were announced from the phase 3 STOP-301 study evaluating INP104 (intranasal dihydroergotamine mesylate; Impel NeuroPharma) for the treatment of acute migraine in adults.
Changes in Brain Function, Amygdalar Connectivity Drive Preventative Effect of CBT on Migraine
The investigators observed greater brain activations in the frontal regions associated with cognitive regulation of pain after CBT.
Case Report: When a Headache Isn’t a Migraine
Chiari malformation is a condition characterized by cerebellar tonsillar herniation of ≥5 mm below the level of the foramen magnum.
Sensory Function Compared Among Patients With Cluster, Migraine, and Tension-Type Headache
Researchers evaluated sensory function in the trigeminocervical region in patients with cluster headache, migraine headache, and tension-type headache.
Menstrual Migraine: Revisiting the Relationship Between Hormonal Events and Migraine
A narrative review summarizes recent data on the pathophysiology, epidemiology, and burden of disease and treatment of menstrual migraine.
Youths With Status Migrainosus: Distinct Subgroup With Poor Short-Term Prognosis
Youth with a history of status migranosus are more likely to experience an increase of >4 headache days per month during a follow-up evaluation.
Novel Class of Preventive Treatments for Migraine
Anti-calcitonin gene-related peptide monoclonal antibodies are the first approved pharmacologic treatments developed explicitly for the prevention of migraine.
-
Loading...
-
Loading...
Next post in Neurology Information Center
